Hiroki Ikeuchi

Frequent mutations that converge on the NFKBIZ pathway in ulcerative colitis

Nobuyuki Kakiuchi, Kenichi Yoshida, Motoi Uchino et al. · Nature · 2019 · 255 citations · Full text

Medicine, Genetics, Molecular Genetics +16

Successful Chemotherapeutic Modality of Doxorubicin Plus Dacarbazine for the Treatment of Desmoid Tumors in Association With Familial Adenomatous Polyposis

Makoto Gega, Hidenori Yanagi, Reigetsu Yoshikawa et al. · Journal of Clinical Oncology · 2005 · 184 citations · Full text

Medicine, Oncology, Pharmacology +17

Scheduled infliximab monotherapy to prevent recurrence of Crohnʼs disease following ileocolic or ileal resection: A 3-year prospective randomized open trial

Kōji Yoshida, Ken Fukunaga, Hiroki Ikeuchi et al. · Inflammatory Bowel Diseases · 2011 · 154 citations · Full text

Pharmacy, Pharmacotherapy, Surgery +14

Risk factors associated with the development of thrombocytopenia in patients who received linezolid therapy

Yoshiko Takahashi, Yoshio Takesue, Kazuhiko Nakajima et al. · Journal of Infection and Chemotherapy · 2010 · 135 citations

Medicine, Hematology, Pharmacology +11

Bioresorbable Hyaluronate-Carboxymethylcellulose Membrane (Seprafilm) in Surgery for Rectal Carcinoma: A Prospective Randomized Clinical Trial

Masato Kusunoki, Hiroki Ikeuchi, Hidenori Yanagi et al. · Surgery Today · 2005 · 118 citations

Medicine, Oncology, Surgery +6